Median Nail Canaliform Dystrophy in Association With Retinoid Therapy

Laura Agnese Pauliņa; Alise Balcere

doi:10.5826/dpc.1303a184

Median Nail Canaliform Dystrophy in Association With Retinoid Therapy

Authors

Laura Agnese Pauliņa Faculty of Medicine, Riga Stradiņš University, Riga, Latvia
Alise Balcere Department of Dermatology and Venereology, Riga Stradiņš University, Riga, Latvia

Keywords:

Drug-induced nail changes, onychopathy, nail plate splitting, onychoscopy

References

Hoy NY, Leung AK, Metelitsa AI, Adams S. New concepts in median nail dystrophy, onychomycosis, and hand, foot, and mouth disease nail pathology. ISRN Dermatol. 2012;2012:680163. DOI: 10.5402/2012/680163. PMID: 22462009. PMCID: PMC3302018.

Khodaee M, Kelley N, Newman S. Median nail dystrophy. CMAJ. 2020;192(50):E1810. DOI: 10.1503/cmaj.201002. PMID: 33318093. PMCID: PMC7759106.

Winther AH, Bygum A. Can median nail dystrophy be an adverse effect of alitretinoin treatment? Acta Derm Venereol. 2014;94(6):719-720. DOI: 10.2340/00015555-1853. PMID: 24691846.

Beckenbach L, Baron JM, Merk HF, Löffler H, Amann PM. Retinoid treatment of skin diseases. Eur J Dermatol. 2015;25(5):384-391. DOI: 10.1684/ejd.2015.2544. PMID: 26069148.

Downloads

Published

2023-07-31

Issue

2023 Vol 13, No 3 | July

Section

Research Letter

License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.

How to Cite

Pauliņa LA, Balcere A. Median Nail Canaliform Dystrophy in Association With Retinoid Therapy. Dermatol Pract Concept. 2023;13(3):e2023184. doi:10.5826/dpc.1303a184